Leukemia Leukemia covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more. http://feeds.nature.com/leu/rss/current Nature Publishing Group en © 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. Leukemia © 2024 Macmillan Publishers Limited, part of Springer Nature. All rights reserved. permissions@nature.com Leukemia https://www.nature.com/uploads/product/leu/rss.gif http://feeds.nature.com/leu/rss/current <![CDATA[ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?]]> https://www.nature.com/articles/s41375-024-02225-7 Leukemia, Published online: 27 March 2024; doi:10.1038/s41375-024-02225-7

ATG or post-transplant cyclophosphamide to prevent GVHD in matched unrelated stem cell transplantation?]]>
Olaf PenackMouad AbouqatebChristophe PeczynskiWilliam BorelandNicolaus KrögerMatthias StelljesTobias Gedde-DahlIgor Wolfgang BlauThomas SchroederUrpu SalmenniemiAlexander KulaginRégis Peffault de LatourStephan MielkeRobert ZeiserIvan MoiseevHélène SchoemansChristian KoeneckeZinaida Peric doi:10.1038/s41375-024-02225-7 Leukemia, Published online: 2024-03-27; | doi:10.1038/s41375-024-02225-7 2024-03-27 Leukemia 10.1038/s41375-024-02225-7 https://www.nature.com/articles/s41375-024-02225-7
<![CDATA[Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial]]> https://www.nature.com/articles/s41375-024-02231-9 Leukemia, Published online: 27 March 2024; doi:10.1038/s41375-024-02231-9

Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial]]>
Michael OertelMarita ZiepertFabian FrontzekNina NackeBettina AltmannMaike NickelsenBertram GlassViola PoeschelChristian RuebeGeorg LenzNorbert SchmitzHans Theodor Eich doi:10.1038/s41375-024-02231-9 Leukemia, Published online: 2024-03-27; | doi:10.1038/s41375-024-02231-9 2024-03-27 Leukemia 10.1038/s41375-024-02231-9 https://www.nature.com/articles/s41375-024-02231-9
<![CDATA[Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients]]> https://www.nature.com/articles/s41375-024-02230-w Leukemia, Published online: 27 March 2024; doi:10.1038/s41375-024-02230-w

Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patients]]>
Shai ShimonyJacqueline S. GarciaJulia KeatingEvan C. ChenMarlise R. LuskinMaximilian StahlDonna S. NeubergDaniel J. DeAngeloRichard M. StoneR. Coleman Lindsley doi:10.1038/s41375-024-02230-w Leukemia, Published online: 2024-03-27; | doi:10.1038/s41375-024-02230-w 2024-03-27 Leukemia 10.1038/s41375-024-02230-w https://www.nature.com/articles/s41375-024-02230-w
<![CDATA[Are there new relevant therapeutic endpoints in the modern era of the <i>BCR::ABL1</i> tyrosine kinase inhibitors in chronic myeloid leukemia?]]> https://www.nature.com/articles/s41375-024-02229-3 Leukemia, Published online: 26 March 2024; doi:10.1038/s41375-024-02229-3

Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?]]>
BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?]]> Hagop KantarjianSusan BranfordMassimo BrecciaJorge CortesFadi G. HaddadAndreas HochhausTimothy HughesGhayas C. IssaElias JabbourFranck E. NicoliniKoji SasakiFrancois Xavier-Mahon doi:10.1038/s41375-024-02229-3 Leukemia, Published online: 2024-03-26; | doi:10.1038/s41375-024-02229-3 2024-03-26 Leukemia 10.1038/s41375-024-02229-3 https://www.nature.com/articles/s41375-024-02229-3
<![CDATA[Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy]]> https://www.nature.com/articles/s41375-024-02208-8 Leukemia, Published online: 26 March 2024; doi:10.1038/s41375-024-02208-8

Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy]]>
Eduardo Sabino de Camargo MagalhãesStefan Edward HubnerBrandon Douglas BrownYihua QiuSteven Mitchell Kornblau doi:10.1038/s41375-024-02208-8 Leukemia, Published online: 2024-03-26; | doi:10.1038/s41375-024-02208-8 2024-03-26 Leukemia 10.1038/s41375-024-02208-8 https://www.nature.com/articles/s41375-024-02208-8
<![CDATA[Measurable residual disease quantification in adult patients with <i>KMT2A</i>-rearranged acute lymphoblastic leukemia]]> https://www.nature.com/articles/s41375-024-02209-7 Leukemia, Published online: 22 March 2024; doi:10.1038/s41375-024-02209-7

Measurable residual disease quantification in adult patients with KMT2A-rearranged acute lymphoblastic leukemia]]>
KMT2A-rearranged acute lymphoblastic leukemia]]> Thomas BurmeisterAeint-Steffen StröhBritta KehdenHeiko TrautmannClaus MeyerRolf MarschalekPatrizia LargheroStefan SchwartzBjörn SteffenBernd SpriewaldThomas HeinickeNadja JäkelJörg WestermannKathrin NachtkampAndreas ViardotMax S. ToppMartin NeumannClaudia D. BaldusNicola GökbugetMonika Brüggemann doi:10.1038/s41375-024-02209-7 Leukemia, Published online: 2024-03-22; | doi:10.1038/s41375-024-02209-7 2024-03-22 Leukemia 10.1038/s41375-024-02209-7 https://www.nature.com/articles/s41375-024-02209-7
<![CDATA[The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia]]> https://www.nature.com/articles/s41375-024-02221-x Leukemia, Published online: 22 March 2024; doi:10.1038/s41375-024-02221-x

The Eμ-Ret mouse is a novel model of hyperdiploid B-cell acute lymphoblastic leukemia]]>
Ali FarrokhiTanmaya AtreJenna ReverMario FidanzaWendy DueySamuel SalitraJunia MyungMeiyun GuoSumin JoAnuli UzozieFatemeh BaharvandNina RolfFranziska AuerJulia HauerStephan A. GruppPatrice EydouxPhilipp F. LangeAlix E. SeifChristopher A. MaxwellGregor S. D. Reid doi:10.1038/s41375-024-02221-x Leukemia, Published online: 2024-03-22; | doi:10.1038/s41375-024-02221-x 2024-03-22 Leukemia 10.1038/s41375-024-02221-x https://www.nature.com/articles/s41375-024-02221-x
<![CDATA[Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche]]> https://www.nature.com/articles/s41375-024-02226-6 Leukemia, Published online: 21 March 2024; doi:10.1038/s41375-024-02226-6

Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche]]>
Susann WinterKatharina S. GötzeJudith S. HeckerKlaus H. MetzelerBorhane GuezguezKevin WoodsHind MedyoufAlexander SchäfferMarc SchmitzRebekka WehnerIngmar GlaucheIngo RoederMartina RaunerLorenz C. HofbauerUwe Platzbecker doi:10.1038/s41375-024-02226-6 Leukemia, Published online: 2024-03-21; | doi:10.1038/s41375-024-02226-6 2024-03-21 Leukemia 10.1038/s41375-024-02226-6 https://www.nature.com/articles/s41375-024-02226-6